Comparison of hematological parameters, iron levels, and oxidative stress in women with and without breast cancer: A case- control study

• Published in: Medical journal of the Islamic Republic of Iran Vol. 31; no. 1; pp. 114 - 767
• Main Authors: Rajizadeh, Afsaneh, Mozaffari-Khosravi, Hassan, Zavar-Reza, Javad, Shiryazdi, Seyyed Mostafa
• Format: Journal Article
• Language: English
• Published: Iran Iran University of Medical Sciences 2017
• Subjects: Original; Premenopausal; Oxidative stress; Breast cancer; Iron status
• ISSN: 1016-1430; 2251-6840
• DOI: 10.14196/mjiri.31.114

Iron is one of the nutrients that has recently received considerable attention because of its dual role in the incidence of breast cancer. The present study aimed at comparing hematological parameters, iron levels, and oxidative stress in women with and without breast cancer. The participants in this case-control study were 55 women, of whom 26 were new cases of breast cancer (confirmed by biopsy) as the case, and 29 without cancer (confirmed by mammography) as the control group. All participants underwent blood testing for complete blood count (CBC (free iron, ferritin, total iron binding capacity) TIBC (2, 2-diphenyl-1-picrylhydrazyl (DPPH), and Malondialdehyde (MDA). The mean±SD age of the participants was 44.25±9.82 years, and there was no significant difference between groups. Also, no statistically significant difference was found between the 2 groups in variables, except the mean corpuscular volume of red cells (MCV), mean corpuscular hemoglobin concentration (MCHC), and mean cell hemoglobin (MCH). The use of iron supplements was significantly higher in the control than in the case group (p= 0. 01), with an odds ratio of 0.19% (95% CI: 0.45-0.7). The mean serum DPPH was significantly higher in the control than in the case group (p= 0. 006), but comparison of serum MDA showed no significant difference between the 2 groups. : Iron deficiency anemia was greater in patients with breast cancer than in those without it. Moreover, iron supplementation appears to have a protective effect against breast cancer incidence. In addition, serum DPPH, as a total antioxidant index, was significantly higher in the control group.